Search

Search results

4 results found

Spatial Technologies Unit (STU) Now a DF/HCC Core

News: May 28, 2025

We’re excited to share that the Spatial Technologies Unit (STU) is now officially recognized as a Dana Farber Harvard Cancer Center DF/HCC Core. This new designation means that DF/HCC members are eligible for internal pricing on STU services, supported in part by the Cancer Center Support Grant...

Delivery Unit from Precision RNA Medicine Core Powers New RNA-Based Cancer Therapy

News: May 05, 2025

In a recent Nature Communications study, Dr. Annalisa Di Ruscio and team introduced aptaDiR, a novel RNA therapeutic engineered to silence DNMT1 and reverse abnormal DNA methylation in cancer. Delivered via lipid nanoparticles, aptaDiR reactivated tumor-suppressor genes and significantly reduced...

BIDMC Glycomics Core Overview with Dr. Lauren Pepi

Events: Monday, Jun 02, 2025, 12:00pm -Monday, Jun 02, 2025, 01:00pm

Join us for a lunchtime talk with Dr. Lauren Pepi, Director of the Glycomics Core at BIDMC. Dr. Pepi will provide an introduction to the Glycomics Core, including available services, technologies, and how the core supports investigators across research areas. This is a great opportunity to learn how...

New advances in miRNA biomarker research, powered by BIDMC's Detection Unit

News: May 21, 2025

Two new studies, presented at HiRM and AACR, identified promising RNA biomarkers in breast cancer and Hodgkin lymphoma. At the heart of both efforts was the Detection Unit at BIDMC’s Precision RNA Medicine Core. What made these discoveries possible? High-throughput miRNA screening using Mirxes qPCR...